GCVRZ - Sanofi CONTGNT VAL RT

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201731/12/201631/12/201531/12/2014
Total revenue36,204,00034,708,00034,861,00031,999,000
Cost of revenue11,428,00010,702,00010,919,00010,230,000
Gross profit24,776,00024,006,00023,942,00021,769,000
Operating expenses
Research development5,472,0005,172,0005,082,0004,667,000
Selling general and administrative10,150,0009,600,0009,496,0008,565,000
Non-recurring----
Others-81,00021,00016,000-296,000
Total operating expenses28,835,00027,187,00027,650,00025,247,000
Operating income or loss7,369,0007,521,0007,211,0006,752,000
Income from continuing operations
Total other income/expenses net-1,735,000-1,709,000-1,990,000-1,146,000
Earnings before interest and taxes7,369,0007,521,0007,211,0006,752,000
Interest expense-277,000-274,000-331,000-357,000
Income before tax5,634,0005,812,0005,221,0005,606,000
Income tax expense1,722,0001,326,000709,0001,214,000
Minority interest169,000170,000161,000148,000
Net income from continuing ops3,912,0004,486,0004,512,0004,392,000
Non-recurring events
Discontinued operations4,643,000314,000-124,000117,000
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income8,434,0004,709,0004,287,0004,390,000
Preferred stock and other adjustments----
Net income applicable to common shares8,434,0004,709,0004,287,0004,390,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes